Clinical

Videos

“Patients want to see an improvement. They want a drug that obviously is efficacious and safe, where the side effects are low,” says David Staskin, MD.

Dr. Staskin discusses counseling patients on vibegron for OAB

“[These patients] have very limited treatment options and the adult muscle derived cells for sphincter regeneration represent a non-surgical means to provide very durable and effective support for these women who have suffered mightily from stress incontinence, oftentimes for long periods of time,” says Melissa R. Kaufman, MD, PhD, FACS.

Advantages of the AMDC-USR technology for patients with SUI 

“We believed that the drug would work as well in OAB wet as [it did] in OAB dry, so we're pleased to see that it was statistically significantly better than placebo at the 12 week point for looking at response to those metrics,” says David Staskin, MD.

Dr. Staskin assesses vibegron outcomes for patients with OAB dry

Podcasts

“We're not saying a blanket stop for all patients, but I think we do need to be taking each patient as an individual in terms of their backgrounds,” says Jai Seth, MD.

Dr. Seth assesses the bleeding risk of Botox treatments in patients who take blood thinners

“This technology is truly a transformational opportunity for urology,” says Melissa R. Kaufman, MD, PhD, FACS.

Dr. Kaufman hails autologous muscle-derived cells as "transformational" SUI treatment

“We are truly embarking at this moment on the next frontier in urology with these types of cellular therapies,” says Melissa R. Kaufman, MD, PhD. 

The success of cellular therapies in patients with SUI

Articles

Patients who received mid-urethral slings at higher-volume medical centers had a lower risk of reoperation. 

Surgical center size significant to reoperation risk after mid urethral sling

Get ready for the 2021 AUA annual meeting with this preview of non-malignant topics.

AUA virtual meeting preview: BPH, stones, and incontinence

“The notable feature was that the bleeding risk is very small. In our particular group, it was less than 1%,” says Jai Seth, MD.

Bleeding risk in patients using Botox treatments and blood thinners

“In terms of patients having Botox, we have to be individualized to some extent where if you feel someone's at very high risk of bleeding…then maybe you will stop the blood thinners,” says Jai Seth, MD.

OAB and Incontinence